Blockchain Registration Transaction Record

Annovis Bio to Showcase Alzheimer’s Therapy Advances at AAIC 2025

Annovis Bio to present at AAIC 2025 on Alzheimer’s therapy buntanetap, showcasing Phase III trial design and pharmacokinetic data. A leap forward in neurodegenerative disease treatment.

This news is crucial for patients, families, and researchers battling neurodegenerative diseases. Annovis Bio's presentation at the AAIC represents a significant step forward in the development of therapies that could potentially restore brain function and improve the lives of millions affected by Alzheimer’s and Parkinson’s. The detailed pharmacokinetic data and Phase III trial design insights offer hope for more effective treatments, underscoring the importance of continued investment and research in neurodegenerative disease therapies.